| CATEGORY: RISERS AND FALLERS SECTOR: PHARMACEUTICALS & BIOTECHNOLOGY |
TechMARK movers: FDA delays SkyePharma approval |
|
Tue 05 Feb 2008
|
LONDON (SHARECAST) - Shares in SkyePharma fell after the biotech said US regulators have delayed the final approval of its once-a-day Parkinson's disease treatment Requip XL.
The Food and Drug Administration is now expected to make a decision in the second quarter of this year.
Semiconductors firm Wolfson Microelectronics was also among today’s fallers despite yesterday's 36% rise in fourth quarter revenue. Profit takers also emerged.
FTSE TechMARK - Fallers
Parity Group (PTY) 40.25p -10.56%
Alphameric (ALM) 24.00p -5.88%
Phytopharm (PYM) 22.25p -5.32%
ARC International (ARK) 27.25p -5.22%
Axon Group (AXO) 491.00p -4.57%
Wolfson Microelectronics (WLF) 162.25p -3.99%
Skyepharma (SKP) 12.50p -3.85%
Genus (GNS) 665.00p -3.48%
NXT (NTX) 8.13p -2.98%
Emblaze (BLZ) 49.00p -2.97%
FTSE TechMARK - Risers
Microgen (MCGN) 40.00p +8.11%
Alizyme (AZM) 44.00p +7.32%
GB Group (GBG) 29.00p +6.42%
Vislink (VLK) 39.50p +6.04%
Telspec (TSP) 5.88p +4.44%
Dicom Group (DCM) 156.00p +4.35%
Torotrak (TRK) 24.50p +4.26%
Total Systems (TTS) 26.00p +4.00%
KCOM Group (KCOM) 46.00p +3.95%
Optos (OPTS) 148.00p +3.86%
|
|
| |
|
 |
Archived Stories |
 |
|
Front Page Stories |
|
|
